Article Details
Retrieved on: 2018-01-27 06:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The company has built a strong R and D structure, with multiple patents to its credit in the wound healing, mucoadhesive drug delivery, and hemostats space. Apart from the Tata emeritus, existing investors <b>Accel Partners</b> and IDG Ventures India also participated in this round of funding. Previous News.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here